Literature DB >> 12925230

The current state and future of clonality studies in mycosis fungoides.

Dan Jones1, Madeleine Duvic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12925230     DOI： 10.1046/j.1523-1747.2003.12458.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  3 in total

1.  Combined use of PCR-based TCRG and TCRB clonality tests on paraffin-embedded skin tissue in the differential diagnosis of mycosis fungoides and inflammatory dermatoses.

Authors:  Bing Zhang; Andrew H Beck; Janis M Taube; Sabine Kohler; Katie Seo; Jeffrey Zwerner; Natalie Viakhereva; Uma Sundram; Youn H Kim; Iris Schrijver; Daniel A Arber; James L Zehnder
Journal:  J Mol Diagn       Date:  2010-03-04       Impact factor: 5.568

Review 2.  Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Authors:  Henry K Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
Journal:  Br J Haematol       Date:  2011-08-25       Impact factor: 6.998

3.  T-plastin (PLS3) gene expression differentiates Sézary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression.

Authors:  N Tang; H Gibson; T Germeroth; P Porcu; H W Lim; H K Wong
Journal:  Br J Dermatol       Date:  2009-11-30       Impact factor: 9.302
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.